Glen Eagle Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-400	Closed	-$9.56K	–	938
2021 Q3	$9.56K	Buy	400 +160	+67%	+$3.82K	﹤0.01%	705
2021 Q2	$6.55K	Buy	+240	New	+$6.55K	﹤0.01%	774